"Alzheimer Disease" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A degenerative disease of the BRAIN characterized by the insidious onset of DEMENTIA. Impairment of MEMORY, judgment, attention span, and problem solving skills are followed by severe APRAXIAS and a global loss of cognitive abilities. The condition primarily occurs after age 60, and is marked pathologically by severe cortical atrophy and the triad of SENILE PLAQUES; NEUROFIBRILLARY TANGLES; and NEUROPIL THREADS. (From Adams et al., Principles of Neurology, 6th ed, pp1049-57)
Descriptor ID |
D000544
|
MeSH Number(s) |
C10.228.140.380.100 C10.574.945.249 F03.615.400.100
|
Concept/Terms |
Alzheimer Disease- Alzheimer Disease
- Alzheimer's Disease
- Dementia, Senile
- Senile Dementia
- Dementia, Alzheimer Type
- Alzheimer Type Dementia
- Alzheimer-Type Dementia (ATD)
- Alzheimer Type Dementia (ATD)
- Dementia, Alzheimer-Type (ATD)
- Alzheimer Type Senile Dementia
- Primary Senile Degenerative Dementia
- Dementia, Primary Senile Degenerative
- Alzheimer Sclerosis
- Sclerosis, Alzheimer
- Alzheimer Syndrome
- Alzheimer Dementia
- Alzheimer Dementias
- Dementia, Alzheimer
- Dementias, Alzheimer
- Senile Dementia, Alzheimer Type
Familial Alzheimer Disease (FAD)- Familial Alzheimer Disease (FAD)
- Alzheimer Disease, Familial (FAD)
- Alzheimer Diseases, Familial (FAD)
- Familial Alzheimer Diseases (FAD)
|
Below are MeSH descriptors whose meaning is more general than "Alzheimer Disease".
Below are MeSH descriptors whose meaning is more specific than "Alzheimer Disease".
This graph shows the total number of publications written about "Alzheimer Disease" by people in this website by year, and whether "Alzheimer Disease" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1994 | 3 | 1 | 4 |
1995 | 3 | 0 | 3 |
1996 | 3 | 1 | 4 |
1997 | 8 | 0 | 8 |
1998 | 3 | 1 | 4 |
1999 | 7 | 0 | 7 |
2000 | 6 | 4 | 10 |
2001 | 6 | 2 | 8 |
2002 | 6 | 2 | 8 |
2003 | 12 | 8 | 20 |
2004 | 10 | 3 | 13 |
2005 | 15 | 5 | 20 |
2006 | 21 | 2 | 23 |
2007 | 16 | 2 | 18 |
2008 | 16 | 3 | 19 |
2009 | 22 | 5 | 27 |
2010 | 36 | 7 | 43 |
2011 | 32 | 6 | 38 |
2012 | 30 | 6 | 36 |
2013 | 28 | 4 | 32 |
2014 | 23 | 4 | 27 |
2015 | 16 | 6 | 22 |
2016 | 20 | 3 | 23 |
2017 | 25 | 2 | 27 |
2018 | 22 | 2 | 24 |
2019 | 25 | 1 | 26 |
2020 | 28 | 2 | 30 |
2021 | 35 | 3 | 38 |
2022 | 36 | 0 | 36 |
2023 | 30 | 2 | 32 |
2024 | 6 | 0 | 6 |
To return to the timeline,
click here.
Below are the most recent publications written about "Alzheimer Disease" by people in Profiles.
-
Nonalcoholic Fatty Liver Disease and Longitudinal Change in Imaging and Plasma Biomarkers of Alzheimer Disease and Vascular Pathology. Neurology. 2024 Apr 09; 102(7):e209203.
-
Advances in nanoprobes for molecular MRI of Alzheimer's disease. Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2024 Mar-Apr; 16(2):e1946.
-
Gantenerumab in Early Alzheimer's Disease. Reply. N Engl J Med. 2024 Feb 29; 390(9):867.
-
The Effect of Bacterial Composition Shifts in the Oral Microbiota on Alzheimer's Disease. Curr Mol Med. 2024; 24(2):167-181.
-
Research Participants' Perspectives on Precision Diagnostics for Alzheimer's Disease. J Alzheimers Dis. 2024; 97(3):1261-1274.
-
The Role of the Anterior Thalamic Nuclei in the Genesis of Memory Disorders in Alzheimer's Disease: An Exploratory Study. J Alzheimers Dis. 2024; 97(1):507-519.
-
Use of the Spanish English Neuropsychological Assessment Scale in older adult Latines and those at risk for autosomal dominant Alzheimer's disease. J Clin Exp Neuropsychol. 2023 Aug; 45(6):553-569.
-
Behavioral or neuropsychiatric symptoms of Alzheimer's disease: from psychopathology to pharmacological management. Arq Neuropsiquiatr. 2023 Dec; 81(12):1152-1162.
-
The BrainLat project, a multimodal neuroimaging dataset of neurodegeneration from underrepresented backgrounds. Sci Data. 2023 Dec 09; 10(1):889.
-
Two Phase 3 Trials of Gantenerumab in Early Alzheimer's Disease. N Engl J Med. 2023 Nov 16; 389(20):1862-1876.